INTC vs PPCB · rev $52.85B vs P/E 0.0, $3.9M cap
Intel Corporation (INTC) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
Intel Corporation (INTC) is a semiconductors company listed on US. It is led by Pat Gelsinger.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported INTC revenue for 2025-12-27 was $52.85B. Net income was -$267.0M. Revenue was down 0.5% from 2024-12-28 to 2025-12-27. INTC currently screens at market cap $498.43B.
PPCB does not have a complete income-statement cache yet.
INTC currently screens at market cap $498.43B. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the INTC and PPCB stock pages for the full models.
Not investment advice.